RxSight, Inc.
RXST
$12.62
-$0.47-3.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.41% | 12.29% | 40.34% | 43.52% | 44.23% |
| Total Depreciation and Amortization | -29.80% | -22.74% | -25.43% | -14.59% | 1.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | 61.33% | 48.06% | 37.19% | 39.27% | 30.22% |
| Change in Net Operating Assets | -2.24% | 21.02% | -79.98% | -1.53% | -15.04% |
| Cash from Operations | 11.11% | 43.22% | 50.30% | 59.26% | 55.49% |
| Capital Expenditure | 42.76% | 29.16% | 32.91% | -13.00% | -72.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.89% | 149.58% | -274.52% | -442.14% | -607.45% |
| Cash from Investing | 128.96% | 139.65% | -303.39% | -348.78% | -489.72% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 43.37% | 99.81% | 99.92% | 99.90% | 99.86% |
| Issuance of Common Stock | -95.46% | -93.13% | 137.98% | 21.67% | 18.81% |
| Repurchase of Common Stock | 56.82% | -25.87% | -25.87% | -235.14% | -235.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 79.09% | 70.77% | 73.12% | 76.17% |
| Cash from Financing | -96.95% | -95.48% | 2,621.25% | 100.44% | 92.79% |
| Foreign Exchange rate Adjustments | -45.45% | 1,600.00% | -100.00% | -250.00% | -8.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -200.00% |
| Net Change in Cash | 88.69% | 1.95% | -121.34% | 421.76% | 711.23% |